Dr. Rémi Rabasa-Lhoret
Claim this profileInstitut de recherches cliniques de Montréal
Studies Type 1 Diabetes
Studies Postprandial Metabolism
7 reported clinical trials
17 drugs studied
Affiliated Hospitals
Clinical Trials Rémi Rabasa-Lhoret is currently running
High-Intensity Exercise
for Type 1 Diabetes
The objective of this study is to investigate if the addition of a 12-week program of home-based high intensity interval training to a standard educational program aiming at preventing hypoglycemia episodes will restore hypoglycemia awareness in people living with type 1 diabetes and impaired awareness of hypoglycemia to a further extent than a standard educational program alone. Participants will be randomized for 12 weeks to the standard educational program with or without high intensity interval training. The Gold method will be used to identify people with impaired awareness of hypoglycemia. The educational program will consist of two education sessions on avoidance of hypoglycemia, causes of hypoglycemia, treatment (e.g. glucagon) of hypoglycemia, how to better recognize hypoglycemia symptoms, understand how to use a CGM/Flash-GM and understand CGM/Flash-GM reports to adjust insulin doses. Participants randomized to the training program will be asked to train three times per week for 12 weeks following the home-based program that will be provided to them. Participants will be asked to perform at least 2 training sessions per week (ideally all 3 sessions) with the exercise specialist on a virtual platform.
Recruiting1 award N/A7 criteria
Exercise Blood Glucose Management
for Type 1 Diabetes
Despite major technological advances in type 1 diabetes (artificial pancreas), the management of hypoglycemia remains a major challenge, especially during and after physical activity. The primary outcome is to determine the temporary blood glucose (BG) target to be set 60 minutes before aerobic exercise in people with type 1 diabetes (PWT1D) using do-it-yourself automated insulin delivery (DIY-AID) systems. Three glycemic thresholds to be applied 60 minutes before physical activity will be tested in 32 people on AID-DIY: 8.3 (current target for commercial AID systems), 8.8, and 9.3 mmol/L. Each participant will perform 3 sessions of moderate aerobic physical activity (ergocycle) at 60% of vo2peak with a different glycemic target each time (random order). Plasma glucose will be measured every 20 minutes before and during physical activity, and blood glucose measured by continuous glucose reading (DEXCOM) for 24 hours post-intervention. Once the best glycemic target is selected, participants could come to the research center for 1 or 2 more voluntary interventions to test the threshold during 1) fasting exercise and 2) late luteal phase of the menstrual cycle.
Recruiting1 award N/A7 criteria
More about Rémi Rabasa-Lhoret
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Rémi Rabasa-Lhoret has experience with
- Insulin
- Home-based High Intensity Interval Training
- Physical Activity Trial Intervention
- Aspart Or Lispro
- Continuous Glucose Monitoring System
- Insulin Pump
Breakdown of trials Rémi Rabasa-Lhoret has run
Type 1 Diabetes
Postprandial Metabolism
Diabetes Mellitus
Loss of Consciousness
Low blood sugar awareness
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rémi Rabasa-Lhoret specialize in?
Rémi Rabasa-Lhoret focuses on Type 1 Diabetes and Postprandial Metabolism. In particular, much of their work with Type 1 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Rémi Rabasa-Lhoret currently recruiting for clinical trials?
Yes, Rémi Rabasa-Lhoret is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Rémi Rabasa-Lhoret has studied deeply?
Yes, Rémi Rabasa-Lhoret has studied treatments such as Insulin, Home-based High Intensity Interval Training, Physical activity trial intervention.
What is the best way to schedule an appointment with Rémi Rabasa-Lhoret?
Apply for one of the trials that Rémi Rabasa-Lhoret is conducting.
What is the office address of Rémi Rabasa-Lhoret?
The office of Rémi Rabasa-Lhoret is located at: Institut de recherches cliniques de Montréal, Montreal, Quebec H2W1R7 Canada. This is the address for their practice at the Institut de recherches cliniques de Montréal.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.